PARP Inhibitors Plus Immunotherapy May Be the Future in Ovarian Cancer – Curetoday.com
Curetoday.com |
PARP Inhibitors Plus Immunotherapy May Be the Future in Ovarian Cancer
Curetoday.com The future of treating ovarian cancer may lie in combinations of immunotherapy plus PARP inhibitors, says Samir N. Khleif, M.D.. Alternatives to chemotherapy are needed for the treatment of ovarian cancer because despite an 80 percent response to … |
